Skip to content
Rentokil Initial PLC

Trian Fund Management Rentokil Initial PLC transactions over time

RTO

Rentokil Initial PLC historical holders

total: 2

Transactions details

Total transactions:
3
New positions:
2
Sold out:
1
Held since:
2026 Q3
Held for:
1 quarter
Latest activity:
2026 Q3
Nelson Peltz has been an institutional investor in Rentokil Initial PLC (RTO) since 2024 Q2. According to 2026 Q3 report, Nelson Peltz holds 596,811 shares with a market value of roughly $11.79M representing 0.45% of their equity portfolio. The fund/company first acquired RTO in 2024 Q2, initially purchasing 470,000 shares. Nelson Peltz later completely sold out the position and reinvested in RTO again in 2026 Q3. Since the initial investment, Trian Fund Management has made 2 more transactions in this position.

Does Nelson Peltz still hold RTO?

Yes, Nelson Peltz continues to hold Rentokil Initial PLC (RTO). According to their 2026 Q3 report, they maintain a position of 596,811 shares valued at approximately $11.79M, representing 0.45% of their equity portfolio.

When did Nelson Peltz first invest in RTO?

Nelson Peltz first invested in Rentokil Initial PLC (RTO) in 2024 Q2 at the reported quarter-end price of $29.65 per share, acquiring 470,000 shares in their initial purchase.

What is Nelson Peltz's average cost basis for RTO?

Based on historical transaction data, Nelson Peltz's estimated cost basis for Rentokil Initial PLC (RTO) is approximately $19.75 per share. This represents their average reported price* across all buy transactions.

Has Nelson Peltz reinvested in RTO after selling?

Yes, Nelson Peltz has shown renewed interest in Rentokil Initial PLC (RTO). After completely selling their position, they reinitiated an investment in 2026 Q3, demonstrating continued conviction in this ticker.

Estimated cost basis*

Weighted AVG buy price:
$19.75

RTO transactions history by Trian Fund Management

3 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q3
0.45%
596,811
$19.75
$11,787,017
new
+0.45%
2024 Q3
0.00%
0
$29.65
-100% (-470,000)
-0.34%
2024 Q2
0.34%
470,000
$29.65
$13,935,500
new
+0.34%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.